Literature DB >> 10890670

What's in a day? Determining intensive care unit length of stay.

P E Marik1, L Hedman.   

Abstract

OBJECTIVE: Intensive care unit (ICU) length of stay (LOS) and hospital LOS are common indices used to compare performance of hospitals and are yardsticks used in efforts to contain costs, yet there is no standardized method of quantitating this outcome variable. Attempts have been made to correct LOS according to disease severity. The aim of this study was to quantify and compare ICU LOS using four commonly used methods and to determine the relationship between severity of illness at admission as determined by the Acute Physiology and Chronic Health Evaluation (APACHE) II and APACHE III scoring systems and LOS.
DESIGN: Prospective, cohort study.
SETTING: Medical and surgical ICUs of a community teaching hospital.
MEASUREMENTS AND MAIN RESULTS: The demographic and clinical data of all patients admitted to the medical ICU and the surgical ICU during a 6-month period were recorded and stored in a computerized database. Coronary care unit boarders and cardiothoracic patients were excluded from analysis. The date and exact time of all admissions and discharges were abstracted from the patients' flowcharts and nurses' notes. The ICU LOS of all patients was calculated using four common methods: a) number of calendar days (LOS-calendar); b) midnight bed-occupancy days (LOS-midnight); c) exact LOS calculated in hours divided by 24 (LOS-exact); and d) the method described by Pollack and Ruttimann (LOS-Pollack). There were 1,004 admissions during the study period; of these, 254 were excluded from analysis (65 coronary care unit boarders and 189 cardiothoracic patients). Of the remaining 750 admissions, 391 were medical ICU patients and 359 were surgical ICU patients. Mean age was 64 +/- 18 yrs, with 420 (56%) male patients. The LOS-calendar differed significantly from the other three methods (p = .001). The LOS-midnight most closely approximated the LOS-exact. The mean (+/- SD) LOS-exact for the entire cohort of patients was 2.8 +/- 3.9 days, with a geometric mean of 1.6 days and a median of 1.4 days. An analysis of the data distribution showed many outliers with the plot markedly skewed to the right. Log transformation of the LOS-exact revealed a normal distribution. The APACHE II and APACHE III scores were significantly higher and the LOS-exact was nonsignificantly higher in the nonsurvivors. There was a poor correlation among the LOS-exact, log LOS-exact, LOS-exact of survivors, and LOS-exact below upper 95th percentile with the APACHE II and APACHE III scores.
CONCLUSION: We suggest that the LOS-midnight be used to record LOS when a hospital/ICU information system is unable to calculate the exact LOS in hours. Furthermore, because the LOS distribution is highly skewed, the geometric mean and median should be reported. Although APACHE II and APACHE III scores are predictive of group outcomes, they should not be used to predict or adjust for LOS.

Entities:  

Mesh:

Year:  2000        PMID: 10890670     DOI: 10.1097/00003246-200006000-00071

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

1.  The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay.

Authors:  William B Hall; Laura E Willis; Sofia Medvedev; Shannon S Carson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

2.  A two-compartment mixed-effects gamma regression model for quantifying between-unit variability in length of stay among children admitted to intensive care.

Authors:  Lahn Straney; Archie Clements; Jan Alexander; Anthony Slater
Journal:  Health Serv Res       Date:  2012-05-17       Impact factor: 3.402

3.  The Prevalence and Molecular Epidemiology of Multidrug-Resistant Enterobacteriaceae Colonization in a Pediatric Intensive Care Unit.

Authors:  Nuntra Suwantarat; Latania K Logan; Karen C Carroll; Robert A Bonomo; Patricia J Simner; Susan D Rudin; Aaron M Milstone; Tsigereda Tekle; Tracy Ross; Pranita D Tamma
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-09       Impact factor: 3.254

4.  A predictive model for the early identification of patients at risk for a prolonged intensive care unit length of stay.

Authors:  Andrew A Kramer; Jack E Zimmerman
Journal:  BMC Med Inform Decis Mak       Date:  2010-05-13       Impact factor: 2.796

5.  Can the experienced ICU physician predict ICU length of stay and outcome better than less experienced colleagues?

Authors:  Fábio Gusmão Vicente; Frederico Polito Lomar; Christian Mélot; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-01-21       Impact factor: 17.440

6.  Critical care medicine in Taiwan from 1997 to 2013 under National Health Insurance.

Authors:  Chih-Cheng Lai; Chung-Han Ho; Chia-Li Chang; Chin-Ming Chen; Shyh-Ren Chiang; Chien-Ming Chao; Jhi-Joung Wang; Kuo-Chen Cheng
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

7.  A review of statistical estimators for risk-adjusted length of stay: analysis of the Australian and new Zealand Intensive Care Adult Patient Data-Base, 2008-2009.

Authors:  John L Moran; Patricia J Solomon
Journal:  BMC Med Res Methodol       Date:  2012-05-16       Impact factor: 4.615

8.  ICUs: from performance appraisal to executive dashboard?

Authors:  Corinne Alberti; Isabelle Durand-Zaleski
Journal:  Intensive Care Med       Date:  2007-06-01       Impact factor: 41.787

9.  Profit and loss analysis for an intensive care unit (ICU) in Japan: a tool for strategic management.

Authors:  Pengyu Cao; Shin-ichi Toyabe; Toshikazu Abe; Kouhei Akazawa
Journal:  BMC Health Serv Res       Date:  2006-01-11       Impact factor: 2.655

10.  Monitoring the impact of the DRG payment system on nursing service context factors in Swiss acute care hospitals: Study protocol.

Authors:  Rebecca Spirig; Elisabeth Spichiger; Jacqueline S Martin; Irena Anna Frei; Marianne Müller; Michael Kleinknecht
Journal:  Ger Med Sci       Date:  2014-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.